Pharmacokinetic Study of Belviq in Adult Korean Volunteers

NCT01880502 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Belviq 10mg
DRUG: Belviq 20mg
DRUG: Placebo

Sponsor

IlDong Pharmaceutical Co Ltd